Literature DB >> 18585642

Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: self-reports of physicians' practices.

Jiska Cohen-Mansfield1, Barbara Jensen.   

Abstract

OBJECTIVES: Behavior problems are common in dementia, yet little is known about how physicians deal with these problems in practice. This article reports on a survey asking physicians to describe, with respect to the last nursing home resident with dementia they treated for behavior problems, the behaviors observed, assessment methods used, suspected etiology of the problem, types of intervention, and their reaction to the intervention process.
DESIGN: This is a descriptive study presenting responses to a Web-based questionnaire. PARTICIPANTS: Participants were 110 physicians providing services to nursing home residents. MEASUREMENTS: Physicians answered a close-ended questionnaire with open-ended "other" options concerning symptoms, methods of assessment, suspected etiological factors, and interventions to describe the last nursing home resident they treated for behavior problems associated with dementia.
RESULTS: Resisting care was the most frequently reported symptom (71%). Physicians were most likely to attribute the behavior problems to the indirect effects of dementia on the ability to remember, communicate, and comprehend (67%). Most (87%) reported using more than one method for treating these problems. Rate of reported use of psychotropic drugs (80%) was slightly higher than that for nonpharmacological methods (75%), with the majority (61%) reporting use of both of these methods. Standardized instruments were not used in assessment. Forty percent of the participants reported feeling satisfied or very satisfied with the intervention they provided, and close to a third (32%) reported feeling frustrated with the intervention process.
CONCLUSION: The data underscore the complexity in the treatment of behavior problems. Despite federal regulations limiting their use, the potential for side effects, and ambivalence toward such treatment, psychotropic drugs are still used for the majority of nursing home residents with behavior problems associated with dementia. On the other hand, physicians report employing nonpharmacological methods to a closely similar extent, although their role in the implementation of these treatments is less clear. Further work is needed to clarify physicians' involvement in and decision to use nonpharmacological interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18585642     DOI: 10.1016/j.jamda.2008.02.010

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  6 in total

Review 1.  [Delirium in the elderly].

Authors:  Manfred Gogol
Journal:  Z Gerontol Geriatr       Date:  2008-10-30       Impact factor: 1.281

Review 2.  Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Authors:  Mouna Sawan; Yun-Hee Jeon; Timothy F Chen
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

3.  Staff-reported strategies for prevention and management of resident-to-resident elder mistreatment in long-term care facilities.

Authors:  Tony Rosen; Mark S Lachs; Jeanne Teresi; Joseph Eimicke; Kimberly Van Haitsma; Karl Pillemer
Journal:  J Elder Abuse Negl       Date:  2015-04-20

4.  Medications use among women with dementia: a cohort study.

Authors:  Kailash Thapaliya; Melissa L Harris; Peta M Forder; Julie E Byles
Journal:  Aging Clin Exp Res       Date:  2021-05-26       Impact factor: 3.636

5.  Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia.

Authors:  Francisca Galindo-Garre; Ladislav Volicer; Jenny T van der Steen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-04-10

Review 6.  Pain management in patients with dementia.

Authors:  Wilco P Achterberg; Marjoleine J C Pieper; Annelore H van Dalen-Kok; Margot W M de Waal; Bettina S Husebo; Stefan Lautenbacher; Miriam Kunz; Erik J A Scherder; Anne Corbett
Journal:  Clin Interv Aging       Date:  2013-11-01       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.